1887

Abstract

Invasive infections caused by the important pathogen are often associated with disturbed blood coagulation in the human host, and may in severe cases develop into the life-threatening condition disseminated intravascular coagulation. In this study, the addition of M1 protein to human blood or purified peripheral blood mononuclear cells led to a dose-dependent increase of pro-coagulant activity, which was mediated by an upregulation of tissue factor on monocytes. Analysis of the resulting clots by transmission electron microscopy revealed that the cells were covered with a fibrin network that seemed to originate from the cell surface. Taken together, the results imply an important role for M proteins in the induction of haemostatic disorders in invasive streptococcal infectious diseases.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2006/003285-0
2007-08-01
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/153/8/2458.html?itemId=/content/journal/micro/10.1099/mic.0.2006/003285-0&mimeType=html&fmt=ahah

References

  1. Abraham, E., Reinhart, K., Opal, S., Demeyer, I., Doig, C., Rodriguez, A. L, Beale, R., Svoboda, P., Laterre, P. F. & other authors ( 2003; ). Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290, 238–247.[CrossRef]
    [Google Scholar]
  2. Åkesson, P., Schmidt, K. H., Cooney, J. & Björck, L. ( 1994; ). M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 300, 877–886.
    [Google Scholar]
  3. Beres, S. B., Richter, E. W., Nagiec, M. J., Sumby, P., Porcella, S. F., Deleo, F. R. & Musser, J. M. ( 2006; ). Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A 103, 7059–7064.[CrossRef]
    [Google Scholar]
  4. Berge, A. & Björck, L. ( 1995; ). Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270, 9862–9867.[CrossRef]
    [Google Scholar]
  5. Bisno, A. L., Brito, M. O. & Collins, C. M. ( 2003; ). Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3, 191–200.[CrossRef]
    [Google Scholar]
  6. Bryant, A. E., Hayes-Schroer, S. M. & Stevens, D. L. ( 2003; ). M type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells. Infect Immun 71, 1903–1910.[CrossRef]
    [Google Scholar]
  7. Camerer, E., Huang, W. & Coughlin, S. R. ( 2000; ). Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 97, 5255–5260.[CrossRef]
    [Google Scholar]
  8. Camerer, E., Kataoka, H., Kahn, M., Lease, K. & Coughlin, S. R. ( 2002; ). Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 277, 16081–16087.[CrossRef]
    [Google Scholar]
  9. Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. ( 2005; ). The global burden of group A streptococcal diseases. Lancet Infect Dis 5, 685–694.[CrossRef]
    [Google Scholar]
  10. Collin, M. & Olsén, A. ( 2000; ). Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 36, 1306–1318.
    [Google Scholar]
  11. Creasey, A. A., Chang, A. C., Feigen, L., Wun, T. C., Taylor, F. B., Jr & Hinshaw, L. B. ( 1993; ). Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91, 2850–2860.[CrossRef]
    [Google Scholar]
  12. Cunningham, M. A., Romas, P., Hutchinson, P., Holdsworth, S. R. & Tipping, P. G. ( 1999; ). Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94, 3413–3420.
    [Google Scholar]
  13. Cunningham, M. W. ( 2000; ). Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470–511.[CrossRef]
    [Google Scholar]
  14. de Chateau, M. & Björck, L. ( 1994; ). Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J Biol Chem 269, 12147–12151.
    [Google Scholar]
  15. Doshi, S. N. & Marmur, J. D. ( 2002; ). Evolving role of tissue factor and its pathway inhibitor. Crit Care Med 30, S241–S250.[CrossRef]
    [Google Scholar]
  16. Fischetti, V. A. ( 1989; ). Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2, 285–314.
    [Google Scholar]
  17. Guha, M., O'Connell, M. A., Pawlinski, R., Hollis, A., McGovern, P., Yan, S. F., Stern, D. & Mackman, N. ( 2001; ). Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98, 1429–1439.[CrossRef]
    [Google Scholar]
  18. Herwald, H., Cramer, H., Mörgelin, M., Russell, W., Sollenberg, U., Norrby-Teglund, A., Flodgaard, H., Lindbom, L. & Björck, L. ( 2004; ). M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116, 367–379.[CrossRef]
    [Google Scholar]
  19. Kastern, W., Sjöbring, U. & Björck, L. ( 1992; ). Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Biol Chem 267, 12820–12825.
    [Google Scholar]
  20. Kihlberg, B. M., Cooney, J., Caparon, M. G., Olsén, A. & Björck, L. ( 1995; ). Biological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga. Microb Pathog 19, 299–315.
    [Google Scholar]
  21. Kotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, M. T., Khurshid, A., Green, K., Peeples, J., Wade, J. & other authors ( 2002; ). An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 8, 1398–1404.[CrossRef]
    [Google Scholar]
  22. Lancefield, R. C. ( 1969; ). Current problems in studies of streptococci. J Gen Microbiol 55, 161–163.[CrossRef]
    [Google Scholar]
  23. Levi, M., de Jonge, E. & van der Poll, T. ( 2003; ). Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 16, 43–47.[CrossRef]
    [Google Scholar]
  24. Loken, M. R., Brosnan, J. M., Bach, B. A. & Ault, K. A. ( 1990; ). Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11, 453–459.[CrossRef]
    [Google Scholar]
  25. Mackman, N. ( 2006; ). Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 36, 104–107.[CrossRef]
    [Google Scholar]
  26. Opal, S. M. & Esmon, C. T. ( 2003; ). Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 7, 23–38.
    [Google Scholar]
  27. Påhlman, L. I., Mörgelin, M., Eckert, J., Johansson, L., Russell, W., Riesbeck, K., Soehnlein, O., Lindbom, L., Norrby-Teglund, A. & other authors ( 2006; ). Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 177, 1221–1228.[CrossRef]
    [Google Scholar]
  28. Pawlinski, R., Pedersen, B., Schabbauer, G., Tencati, M., Holscher, T., Boisvert, W., Andrade-Gordon, P., Frank, R. D. & Mackman, N. ( 2004; ). Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 103, 1342–1347.
    [Google Scholar]
  29. Price, G. C., Thompson, S. A. & Kam, P. C. ( 2004; ). Tissue factor and tissue factor pathway inhibitor. Anaesthesia 59, 483–492.[CrossRef]
    [Google Scholar]
  30. Riedemann, N. C., Guo, R. F. & Ward, P. A. ( 2003; ). Novel strategies for the treatment of sepsis. Nat Med 9, 517–524.[CrossRef]
    [Google Scholar]
  31. Roeder, A., Kirschning, C. J., Schaller, M., Weindl, G., Wagner, H., Korting, H. C. & Rupec, R. A. ( 2004; ). Induction of nuclear factor-κB and c-Jun/activator protein-1 via Toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans. J Infect Dis 190, 1318–1326.[CrossRef]
    [Google Scholar]
  32. Stevens, D. L. ( 1992; ). Invasive group A Streptococcus infections. Clin Infect Dis 14, 2–11.[CrossRef]
    [Google Scholar]
  33. Stevens, D. L. ( 2003; ). Group A streptococcal sepsis. Curr Infect Dis Rep 5, 379–386.[CrossRef]
    [Google Scholar]
  34. Sutherland, A. M., Walley, K. R. & Russell, J. A. ( 2005; ). Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 33, 638–644.[CrossRef]
    [Google Scholar]
  35. Taylor, F. B., Chang, A. C., Peer, G., Li, A., Ezban, M. & Hedner, U. ( 1998; ). Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood 91, 1609–1615.
    [Google Scholar]
  36. Van Amersfoort, E. S., Van Berkel, T. J. & Kuiper, J. ( 2003; ). Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16, 379–414.[CrossRef]
    [Google Scholar]
  37. Weineisen, M., Sjöbring, U., Fallman, M. & Andersson, T. ( 2004; ). Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling. J Immunol 172, 3798–3807.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.2006/003285-0
Loading
/content/journal/micro/10.1099/mic.0.2006/003285-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error